SurModics IVD Breakthrough Stabilizer Addresses Industry Challenge

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics IVD, Inc., a wholly owned subsidiary of SurModics, Inc. (NASDAQ:SRDX) and a market leader for in vitro diagnostic assay components, is launching its new StabilZyme® Protein-Free Stabilizer today at the American Association for Clinical Chemistry (AACC) meeting in Houston.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC